The final of the 11th Tsinghua University President's Innovation Challenge was recently held at Jianhua Building. 168 participating teams went through preliminary selection and semi-finals, and 16 teams stood out and advanced to the finals. After four hours of intense competition, the Migrasome Therapeutics team won the first prize.
During the final, 16 teams displayed their strengths and delivered their presentations on the project concept, achievements, and innovation through texts, pictures, and videos.
The winner of the "Meiling" First Prize, the “Migrasome Therapeutics,” has pioneered the development of an engineered migrasome system with a complete quality control process to ensure high-quality production. The system has advantages such as targeted delivery, diverse drug loading types, and reasonable production costs. Dai Chen, the R&D director, said that participating in this contest has inspired their innovative thinking and allowed them to see the infinite possibilities of technological innovation. In the future, the team will double its efforts to quickly apply the original biological discovery of "migrasome" to clinical practice, bringing good news to more patients.
From Tsinghua SEM
Editor: Li Han
